BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25646356)

  • 1. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.
    Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y
    Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
    Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
    Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
    Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
    Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer.
    Machado-Rugolo J; Fabro AT; Ascheri D; Farhat C; Ab'Saber AM; de Sá VK; Nagai MA; Takagaki T; Terra R; Parra ER; Capelozzi VL
    Hum Pathol; 2019 Jan; 83():177-191. PubMed ID: 30218756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases.
    Søes S; Sørensen BS; Alsner J; Overgaard J; Hager H; Hansen LL; Kristensen LS
    Lung Cancer; 2013 Aug; 81(2):180-6. PubMed ID: 23643276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the sites of metastases from lung cancer using molecular biologic markers.
    D'Amico TA; Aloia TA; Moore MB; Conlon DH; Herndon JE; Kinch MS; Harpole DH
    Ann Thorac Surg; 2001 Oct; 72(4):1144-8. PubMed ID: 11603427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
    Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
    Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].
    Ucvet A; Kul C; Gursoy S; Erbaycu AE; Kaya SO; Dinc ZA; Yucel N
    Arch Bronconeumol; 2011 Aug; 47(8):397-402. PubMed ID: 21696876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study on circulating miRNAs in patients after lung cancer resection.
    Leidinger P; Galata V; Backes C; Stähler C; Rheinheimer S; Huwer H; Meese E; Keller A
    Oncotarget; 2015 Jun; 6(18):16674-85. PubMed ID: 26078336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer.
    Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R
    Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value.
    Chen L; Hu X; Wu H; Jia Y; Liu J; Mu X; Wu H; Zhao Y
    Pathol Res Pract; 2019 Mar; 215(3):427-432. PubMed ID: 30455129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
    Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
    Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR
    Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.